Monthly Archives: October 2015

Natural product-based therapy for Diabetes mellitus: δ-tocotrienol, a derivative of vitamin-E, increases islet insulin levels, islet cell mass and glucose tolerance via down regulation of NMDA receptor GluN2A, 7/October/2015, 11.08 pm

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Undisclosed information: How  δ–tocotrienol decreases the expression of NMDA receptor GluN2A Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ A study from the Institute of Metabolic Physiology, Heinrich Heine University, Düsseldorf, Germany shows that: “Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.“ This study was … Continue reading

Posted in Ideas | Comments Off on Natural product-based therapy for Diabetes mellitus: δ-tocotrienol, a derivative of vitamin-E, increases islet insulin levels, islet cell mass and glucose tolerance via down regulation of NMDA receptor GluN2A, 7/October/2015, 11.08 pm

Natural product-based therapy for Colorectal cancer: MiRNA-29b increases the expression of DNA Sensor AIM2 and inhibits expansion of tumor-initiating intestinal stem cell population via up regulation of its target gene, 7/October/2015, 10.55 pm

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Undisclosed information: How MiRNA-29b  increases the expression of tumor suppressor AIM2. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ A recent study from the Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA shows that:  “Critical Role for the DNA Sensor … Continue reading

Posted in Ideas | Comments Off on Natural product-based therapy for Colorectal cancer: MiRNA-29b increases the expression of DNA Sensor AIM2 and inhibits expansion of tumor-initiating intestinal stem cell population via up regulation of its target gene, 7/October/2015, 10.55 pm

Molecular therapy for Human Cancer: Indoleamine 2,3-Dioxygenase 2 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via down regulation of its target gene, 7/October/2015, 10.28 pm

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Undisclosed information: How Indoleamine 2,3-Dioxygenase 2 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; and I.F: >42) stating that “The TEL … Continue reading

Posted in Ideas | Comments Off on Molecular therapy for Human Cancer: Indoleamine 2,3-Dioxygenase 2 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via down regulation of its target gene, 7/October/2015, 10.28 pm